The potential for treatment shortening with higher rifampicin doses: relating drug exposure to treatment response in patients with pulmonary tuberculosis

EM Svensson, RJ Svensson… - Clinical Infectious …, 2018 - academic.oup.com
Background Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

EM Svensson, RJ Svensson… - Clinical Infectious …, 2018 - epub.ub.uni-muenchen.de
Background. Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

The potential for treatment shortening with higher rifampicin doses: relating drug exposure to treatment response in patients with pulmonary tuberculosis

EM Svensson, RJ Svensson… - Clinical …, 2018 - research-portal.st-andrews.ac.uk
Background: Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

[HTML][HTML] The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary …

EM Svensson, RJ Svensson… - … diseases: an official …, 2018 - escholarship.org
BackgroundTuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

[PDF][PDF] The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

EM Svensson, RJ Svensson, LH te Brake, MJ Boeree… - 2018 - repository.ubn.ru.nl
Background: Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.

EM Svensson, RJ Svensson… - Clinical Infectious …, 2018 - search.ebscohost.com
Background. Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

[PDF][PDF] The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

EM Svensson, RJ Svensson… - Clinical Infectious …, 2018 - researchgate.net
Background. Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

The potential for treatment shortening with higher rifampicin doses: relating drug exposure to treatment response in patients with pulmonary tuberculosis

EM Svensson, RJ Svensson… - Clinical …, 2018 - research-repository.st-andrews.ac …
Background: Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

[PDF][PDF] The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

EM Svensson, RJ Svensson… - Clinical Infectious …, 2018 - scienceopen.com
Background. Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …

[PDF][PDF] The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis

EM Svensson, RJ Svensson… - Clinical Infectious …, 2018 - academic.oup.com
Background Tuberculosis remains a huge public health problem and the prolonged
treatment duration obstructs effective tuberculosis control. Higher rifampicin doses have …